COMP <GO>
CYH vs ABBV // EV/EBITDA & P/E VALUATION
Community Health Systems Inc. (NYSE) VS. AbbVie Inc. (NYSE) • 15-METRIC TALLY: CYH 2
— ABBV 8
▲ EV/EBITDA & P/E VALUATION LEADER: CYH
LAST: $2.41 (-9.40%) • MKT CAP: $339.8M
valuation
5.9x
LAST: $290.79 (+1.68%) • MKT CAP: $513.86B
valuation
33.3x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CYH VS. ABBV)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CYH | ABBV | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 85.10% | 70.20% | +14.90 | CYH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 13.50% | 29.00% | -15.50 | ABBV | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 5.9x | 33.3x | -27.40 | CYH | /valuation <GO> |
| Free Cash Flow Yield | — | 3.47% | — | TIE | /fcf-yield <GO> |
| Operating Margin | 11.90% | 24.60% | -12.70 | ABBV | /operating-margins <GO> |
| Net Profit Margin | 4.10% | 6.90% | -2.80 | ABBV | /net-margins <GO> |
| Revenue Growth (YoY) | -1.20% | 8.60% | -9.80 | ABBV | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.27% | -2.27 | ABBV | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.05 | 5.33 | -4.28 | ABBV | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 29.1 | 65.1 | -35.96 | ABBV | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.15 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 113.1x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $339.8M | $513.86B | -$513.52B | ABBV | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CYH REV | ABBV REV | CYH GROSS % | ABBV GROSS % | CYH FCF | ABBV FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $12.48B | $61.16B | 85.1% | 70.2% | $208.0M | $17.82B |
| FY 2024 | $12.63B | $56.33B | 84.6% | 70.0% | $120.0M | $17.83B |
| FY 2023 | $12.49B | $54.32B | — | — | $210.0M | $20.39B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CYH // BETA —
ABBV // BETA 1.15